KIT signaling is dispensable for human mast cell progenitor development

Abstract excerpt

Human hematopoietic progenitors are generally assumed to require stem cell factor (SCF) and KIT signaling during differentiation for the formation of mast cells. Imatinib treatment, which inhibits KIT signaling, depletes mast cells in vivo. Furthermore, the absence of SCF or imatinib treatment prevents progenitors from developing into mast cells in vitro. However, these observations do not mean that mast cell...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Food Allergy and Anaphylaxis Research
• Share to Mast cells and histamine
• Share to Polyamine Metabolism and Applications